Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,890 JPY | -0.51% | +2.91% | +7.61% |
2023 | Dalton Submits Shareholder Proposal to Hogy Medical | CI |
2022 | Tranche Update on Hogy Medical Co.,Ltd.'s Equity Buyback Plan announced on February 8, 2022. | CI |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company appears to be poorly valued given its net asset value.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 29.83 times its estimated earnings per share for the ongoing year.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.61% | 606M | - | ||
+9.48% | 27.43B | B+ | ||
-28.65% | 3.18B | B- | ||
-16.08% | 2.53B | C+ | ||
+19.05% | 2.49B | - | A- | |
+11.11% | 2.16B | B | ||
-4.24% | 2.03B | - | ||
+1.69% | 1.31B | - | ||
+29.73% | 1.29B | C | ||
+8.01% | 1.17B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3593 Stock
- Ratings Hogy Medical Co.,Ltd.